Röpcke Bernd, Eggers Christian
Klinik für Psychiatrie und Psychotherapie des Kindes- und Jugendalters, Rheinische Landes- und Hochschulklinik Essen, Virchowstrasse 174, 45147 Essen, Germany.
Eur Child Adolesc Psychiatry. 2005 Sep;14(6):341-50. doi: 10.1007/s00787-005-0483-6.
The study describes the psychopathological and social outcome of patients treated for schizophrenia in adolescence (mean age at onset 16.0 years/SD 1.52) after a mean follow-up period of 15.4 years (10.2-21.2 years). Out of 55 patients consecutively admitted to hospital, 47 (85 %) could be traced and 39 (71 %) could be re-examined. At follow-up, 33/39 patients (85 %) had had at least one readmission. Full remission of global psychopathological symptoms [Clinical Global Impression (CGI) <or= 2] was found in 3/39 (8 %),a moderate outcome (CGI=3-5) in 22/39 (56 %), and a poor outcome (CGI=6-8) was seen in 14/39 (36 %). Severe or very severe impairments of global social functioning [Global Assessment of Social Function (GAS)< 51] were observed in 20/39 (51 %). The best predictor of global psychopathological and psychosocial outcome was type of onset (CGI: Beta=0.36, GAS: Beta=-0.37). A poor outcome was seen in 22 out of 25 cases with insidious onset. All predictors together explained 58% of the variance in the Positive and Negative Syndrome (PANSS) negative symptom ratings at follow-up. Gender, duration of first inpatient treatment and duration of untreated psychosis were of no predictive value for outcome. The nature of the diagnosis in the first episode strongly predicted the diagnosis given for the whole course after 15 years. In 26/37 cases (70 %), diagnosis at onset and overall diagnoses were the same. Our finding of an incidence of 61% insidious onset is similar to that in adult onset schizophrenia (AOS), but different to very early onset schizophrenia (VEOS), which shows a higher rate of insidious onset, cognitive impairment and poor outcome. Therefore, it seems that VEOS is a special group compared with early onset schizophrenia (EOS) and AOS.
该研究描述了青少年期接受精神分裂症治疗的患者(发病平均年龄16.0岁/标准差1.52)在平均随访15.4年(10.2 - 21.2年)后的精神病理学和社会结局。在连续入院的55例患者中,47例(85%)能够被追踪到,39例(71%)能够接受复查。随访时,39例患者中有33例(85%)至少有一次再次入院。39例患者中有3例(8%)达到全球精神病理学症状完全缓解[临床总体印象量表(CGI)≤2],22例(56%)为中度结局(CGI = 3 - 5),14例(36%)为不良结局(CGI = 6 - 8)。39例患者中有20例(51%)存在严重或非常严重的全球社会功能损害[社会功能总体评估量表(GAS)< 51]。全球精神病理学和心理社会结局的最佳预测因素是起病类型(CGI:β = 0.36,GAS:β = -0.37)。25例隐匿起病的患者中有22例结局不良。所有预测因素共同解释了随访时阳性和阴性症状量表(PANSS)阴性症状评分中58%的变异。性别、首次住院治疗时间和未治疗精神病持续时间对结局无预测价值。首次发作时的诊断性质强烈预测15年后整个病程的诊断。37例中有26例(70%)起病时诊断与总体诊断相同。我们发现隐匿起病发生率为61%,这与成人起病精神分裂症(AOS)相似,但与极早发精神分裂症(VEOS)不同,后者隐匿起病、认知损害和结局不良的发生率更高。因此,与早发精神分裂症(EOS)和AOS相比,VEOS似乎是一个特殊的群体。